These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29162389)

  • 1. Is cryptogenic cirrhosis different from NASH cirrhosis?
    Thuluvath PJ; Kantsevoy S; Thuluvath AJ; Savva Y
    J Hepatol; 2018 Mar; 68(3):519-525. PubMed ID: 29162389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2018 Apr; 102(4):656-663. PubMed ID: 29215462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
    Thuluvath PJ; Hanish S; Savva Y
    Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic cirrhosis and NASH: entities in evolution and involution.
    Mahiuddin Ahammed SK; Chowdhury A
    Trop Gastroenterol; 2014; 35(2):65-70. PubMed ID: 25470867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
    Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
    Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
    Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
    Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for nonalcoholic steatohepatitis in cryptogenic cirrhosis.
    Leite AB; Mattos AA; Mattos AZ; Coral GP; Evaldt S
    Arq Gastroenterol; 2012 Dec; 49(4):245-9. PubMed ID: 23329217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
    Younossi Z; Stepanova M; Sanyal AJ; Harrison SA; Ratziu V; Abdelmalek MF; Diehl AM; Caldwell S; Shiffman ML; Schall RA; McColgan B; Subramanian GM; Myers RP; Muir A; Afdhal NH; Bosch J; Goodman Z
    J Hepatol; 2018 Dec; 69(6):1365-1370. PubMed ID: 30144554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
    Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
    Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study.
    Poonawala A; Nair SP; Thuluvath PJ
    Hepatology; 2000 Oct; 32(4 Pt 1):689-92. PubMed ID: 11003611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
    Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
    Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants.
    O'Leary JG; Landaverde C; Jennings L; Goldstein RM; Davis GL
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):700-704.e1. PubMed ID: 21570483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poor Survival After Retransplantation in NASH Cirrhosis.
    Thuluvath AJ; Chen PH; Thuluvath PJ; Kantsevoy S; Savva Y
    Transplantation; 2019 Jan; 103(1):101-108. PubMed ID: 29470354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic liver disease in diabetes mellitus.
    Amarapurkar D; Das HS
    Trop Gastroenterol; 2002; 23(1):3-5. PubMed ID: 12170918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study.
    Fukushima M; Miyaaki H; Sasaki R; Haraguchi M; Miuma S; Hara T; Soyama A; Hidaka M; Eguchi S; Nakao K
    Intern Med; 2023 May; 62(10):1415-1423. PubMed ID: 36171128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis.
    Tellez-Avila FI; Sanchez-Avila F; García-Saenz-de-Sicilia M; Chavez-Tapia NC; Franco-Guzman AM; Lopez-Arce G; Cerda-Contreras E; Uribe M
    World J Gastroenterol; 2008 Aug; 14(30):4771-5. PubMed ID: 18720537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Waterworth DM; Kendrick S; Sattar N; Alazawi W
    BMC Med; 2019 May; 17(1):95. PubMed ID: 31104631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study.
    Hamid O; Eltelbany A; Mohammed A; Alsabbagh Alchirazi K; Trakroo S; Asaad I
    Ann Hepatol; 2022; 27(5):100727. PubMed ID: 35700934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kobashigawa K; Kinjo F; Saito A
    Hepatogastroenterology; 2003; 50(54):2005-8. PubMed ID: 14696453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
    Bugianesi E; Leone N; Vanni E; Marchesini G; Brunello F; Carucci P; Musso A; De Paolis P; Capussotti L; Salizzoni M; Rizzetto M
    Gastroenterology; 2002 Jul; 123(1):134-40. PubMed ID: 12105842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.